diabetes
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar. Without Ozempic or a similar drug, Cooper Harris suffers blackouts, becomes too tired to watch her grandchildren, and struggles to earn extra money braiding hair. Marcus Harris, who works as a Waffle House cook, needs Trulicity to keep his legs and feet from swelling and bruising. The couple’s doctor has tried prescribing similar drugs, which mimic a hormone that suppresses appetite and control...
Kaiser Health News
La compañía registró un beneficio neto de 3.404 millones de euros, frente a los 2.654 millones de euros del mismo período del año pasado. Supera los 3.093 millones de euros anticipados por los analistas. El beneficio por acción también subió hasta 0,76 euros desde los 0,589 euros del año anterior, lo que indicaría una sólida sorpresa del 8,75% con respecto a las expectativas del mercado. Ventas inesperadasLas ventas del trimestre alcanzaron los 8.747 millones de euros, un 22% más que los 7.135 millones de euros de hace un año, 8.490 millones de euros pronosticados por los analistas bursátiles....
Euronews (Spanish)
The company reported a net profit of DKK 25.41 billion (€3.404 billion), up from DKK 19.81 billion (€2.654 billion) in the same period last year and surpassing the DKK 23.09 billion (€3.093 billion) anticipated by analysts. Earnings per share (EPS) also rose to DKK 5.68 (€0.76) from DKK 4.39 (€0.589) a year prior, indicating a robust 8.75% surprise over market expectations. Sales for the quarter reached DKK 65.35 billion (€8.747 billion), a 22% increase from DKK 53.37 billion (€7.135 billion) a year ago, outperforming the DKK 63.43 billion (€8.490 billion) forecast by analysts. Weight-loss dru...
Euronews (English)
Scientists say stroke, diabetic nerve damage, and dementia are making neurological diseases the biggest cause of ill health globally. According to a recent study00038-3/fulltext#%20) published in the journal Lancet Neurology, researchers from the University of Washington in the US and their international collaborators say neurological conditions now affect 3.4 billion people worldwide. The global counts for total nervous system health loss have increased by 18.2 per cent from 375 million in 1990 to 443 million disability-adjusted life years (DALYs) in 2021. Meet 'Viv,' the AI companion helping...
Euronews (English)
Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pictures taken by a retinal camera. It makes quick diagnoses, without a doctor present. His clinics, Tarzana Treatment Centers, are among the early adopters of an AI-based system that promises to dramatically expand screening for diabetic retinopathy, the leading cause of blindness among working-age adults and a threat to many of the estimated 38 million Americans with diabetes. “It’s been a godsen...
Kaiser Health News
Danish pharmaceutical powerhouse Novo Nordisk has emerged as one of the standout performers among European mega-cap stocks in the early months of this year, boasting a robust 25% surge year to date. This performance further cemented Novo Nordisk's status as the largest European company by market capitalisation, reaching almost €550 billion and outpacing the market value of Tesla. Over the past year, the Danish pharma titan has seen its price jump by 80%, a rate of increase unmatched by any other European company valued at €100 billion or more. Novo Nordisk's growth driver: Weight-loss drug Weg...
Euronews (English)
Washington (AFP) - Drugs like Ozempic, which have become increasingly popular for losing weight, heighten the risk of certain severe gastrointestinal problems including stomach paralysis, according to a large study published Thursday. The paper, published in the Journal of the American Medical Association (JAMA), looked at a class of drugs called GLP-1 agonists that includes the brands Wegovy, Ozempic, Rybelsus and Saxenda. It then compared the rate of serious side effects to another class of weight loss drug, bupropion-naltrexone. The GLP-1 agonists were associated with an almost four times ...
AFP
By Nidhi Jacob A study00119-5/fulltext) backed by the Indian Council of Medical Research has estimated that in India, 136 million people (which is more than the population of Maharashtra) or 15.3% of the population are likely to be pre-diabetic. There is almost no urban-rural divide when it comes to pre-diabetes with 15.4% of the urban population and 15.2% of rural India in the pre-diabetic stage. Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation, according to the World Health Organization. Pre-diabetes is a condition in which a person's bl...
BOOM Live
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら